Icon Cancer Centre

Auchenflower, Queensland 4066

1 studies enrolling now · 2 studies all time

What they study most

HER2-negative Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Myeloproliferative Neoplasms

Studies at this site

• Study of INCA036978 in Participants With Myeloproliferative Neoplasms — Recruiting now
• A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer — Completed